ASHP Advantage® Engaging the Experts

This series includes interviews with leading experts from ASHP Advantage® activities about important therapeutic and practice updates.

Breaking Barriers: Tackling Obesity Myths, Patient Challenges, and Long-term Success (CE)

May 28, 2025

Listen Here

Tailored Treatment Talks: Navigating Obesity Care, Outcomes, and Teamwork (CE)

May 20, 2025

Listen Here

USP <797> and Parenteral Nutrition: What’s New on the Menu (CE)

May 14, 2025

Listen Here

What Pharmacists Need to Know About Myasthenia Gravis

March 19, 2025

Listen Here

How Pharmacists Can Be Engaged in Myasthenia Gravis Care

March 5, 2025

Listen Here

Opioid REMS – Beyond the basics

February 5, 2025

Listen Here

Demystifying Immediate Use: What’s NOT Category 1, 2, or 3

July 3, 2024

Listen Here

FLiRTing with COVID - Are We Out of the Woods Yet?

June 21, 2024

Listen Here

COVID-19: So What’s New?

April 26, 2024

Listen Here

Compliance with USP Chapter <797> in Small and Rural Hospitals

April 17, 2024

Listen Here

Optimizing PARP Inhibitors Through Applying Evolving Technology and Clinical Evidence for Markers of Homologous Recombination Repair

March 20, 2024

Listen Here

What You Need to Know About Obesity and Newer Treatments – Part 2

March 1, 2024

Listen Here

What You Need to Know About Obesity and Newer Treatments – Part 1

February 23, 2024

Listen Here

The Long and Short of Long COVID

November 17, 2023

Listen Here

A New Landscape: Biosimilars in Multiple Sclerosis

September 22, 2023

Listen Here

A New Landscape: Biosimilars in Autoimmune Indications

August 25, 2023

Listen Here

The (COVID-19) Eris Tour

August 25, 2023

Listen Here

Putting the Patient First: Updates in the Management of Acute Agitation

July 28, 2023

Listen Here

Are there PROS of PRObiotics over other Microbiome Restoration Products for C. Difficile Infections?

June 23, 2023

Listen Here

COVID Updates - Pregnancy, Lactation, and Pediatrics

May 26, 2023

Listen Here

What’s the Scoop on Poop in C. difficile Infections?

May 18, 2023

Listen Here

COVID Updates and the End of PHE: What it Means for You

May 14, 2023

Listen Here

Listen to previously featured podcasts of ASHP Advantage

Listen Here

ASHP Advantage® Engaging the Experts

Related Links

Breaking Barriers: Tackling Obesity Myths, Patient Challenges, and Long-term Success (CE)

Tailored Treatment Talks: Navigating Obesity Care, Outcomes, and Teamwork (CE)

USP <797> and Parenteral Nutrition: What’s New on the Menu (CE)

What Pharmacists Need to Know About Myasthenia Gravis

How Pharmacists Can Be Engaged in Myasthenia Gravis Care

Opioid REMS – Beyond the basics

Demystifying Immediate Use: What’s NOT Category 1, 2, or 3

FLiRTing with COVID - Are We Out of the Woods Yet?

COVID-19: So What’s New?

Compliance with USP Chapter <797> in Small and Rural Hospitals

Optimizing PARP Inhibitors Through Applying Evolving Technology and Clinical Evidence for Markers of Homologous Recombination Repair

What You Need to Know About Obesity and Newer Treatments – Part 2

What You Need to Know About Obesity and Newer Treatments – Part 1

The Long and Short of Long COVID

A New Landscape: Biosimilars in Multiple Sclerosis

A New Landscape: Biosimilars in Autoimmune Indications

The (COVID-19) Eris Tour

Putting the Patient First: Updates in the Management of Acute Agitation

Are there PROS of PRObiotics over other Microbiome Restoration Products for C. Difficile Infections?

COVID Updates - Pregnancy, Lactation, and Pediatrics

What’s the Scoop on Poop in C. difficile Infections?

COVID Updates and the End of PHE: What it Means for You